Target intelligence / Profile preview

Novel transcript, antisense to PDCD2

Molecular classification
Long noncoding RNA (lncRNA), Antisense RNA, Other
01

Overview

This entry refers to a novel long noncoding RNA transcript that is antisense to the PDCD2 (Programmed cell death protein 2) gene, annotated as ENSG00000267024 in Ensembl and LOC124904695 in some NCBI/RefSeq records. It is mapped as an antisense RNA overlapping the PDCD2 gene locus, potentially regulating PDCD2 expression via transcriptional interference, a phenomenon described for similar conserved antisense transcripts in mouse, chicken, and human[2]. However, there is no published experimental evidence attributing a confirmed biological function, disease association, or relevance as a therapeutic target, biomarker, or drug-interacting molecule[5][2]. Entries like this in genomic datasets often remain poorly characterized ("novel transcript" status), with some considered possible artifacts or incomplete annotation, as suggested by transcriptome studies[2]. Its principal relevance is as a genomic feature that may participate in regulatory mechanisms, not as a target for drug discovery or clinical intervention.

Other names
ENSG00000267024LOC124904695AC008747.1Novel transcript, antisense to PDCD2
02

Mechanism of action

None established; antisense transcripts may interfere with sense transcription through transcriptional interference or RNA-based mechanisms, but specific drugs/mechanisms do not exist for this target

03

Biological functions

May participate in transcriptional regulation of PDCD2 via antisense interferenceCould affect cell death regulation or cell proliferation indirectly if modulating PDCD2 expressionOther
04

Disease associations

No established direct disease associationThe region of PDCD2 is noted in some studies to be relevant in lymphoma and leukemias, but this is for PDCD2, not its antisense RNA

Beyond the preview

Go deeper on Novel transcript, antisense to PDCD2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to PDCD2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call